Because of the diverse expression of PTEN in normal tissues and individual tumors, as well as the crucial role of subtle variations of PTEN concentration for cancer phenotype development [12], there is a need for a more sophisticated immunohistochemistry scoring method. The gene discussed is PTEN; the disease is cancer.